Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
294.73
-20.40 (-6.47%)
At close: May 1, 2026, 4:00 PM EDT
295.00
+0.27 (0.09%)
After-hours: May 1, 2026, 7:59 PM EDT
Stryker Revenue
Stryker had revenue of $6.02B in the quarter ending March 31, 2026, with 2.63% growth. This brings the company's revenue in the last twelve months to $25.27B, up 8.84% year-over-year. In the year 2025, Stryker had annual revenue of $25.12B with 11.16% growth.
Revenue (ttm)
$25.27B
Revenue Growth
+8.84%
P/S Ratio
4.47
Revenue / Employee
$451,250
Employees
56,000
Market Cap
112.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.12B | 2.52B | 11.16% |
| Dec 31, 2024 | 22.60B | 2.10B | 10.23% |
| Dec 31, 2023 | 20.50B | 2.05B | 11.11% |
| Dec 31, 2022 | 18.45B | 1.34B | 7.84% |
| Dec 31, 2021 | 17.11B | 2.76B | 19.21% |
| Dec 31, 2020 | 14.35B | -533.00M | -3.58% |
| Dec 31, 2019 | 14.88B | 1.28B | 9.43% |
| Dec 31, 2018 | 13.60B | 1.16B | 9.30% |
| Dec 31, 2017 | 12.44B | 1.12B | 9.88% |
| Dec 31, 2016 | 11.33B | 1.38B | 13.86% |
| Dec 31, 2015 | 9.95B | 271.00M | 2.80% |
| Dec 31, 2014 | 9.68B | 654.00M | 7.25% |
| Dec 31, 2013 | 9.02B | 364.00M | 4.20% |
| Dec 31, 2012 | 8.66B | 350.00M | 4.21% |
| Dec 31, 2011 | 8.31B | 987.00M | 13.48% |
| Dec 31, 2010 | 7.32B | 597.00M | 8.88% |
| Dec 31, 2009 | 6.72B | 4.80M | 0.07% |
| Dec 31, 2008 | 6.72B | 717.70M | 11.96% |
| Dec 31, 2007 | 6.00B | 853.30M | 16.58% |
| Dec 31, 2006 | 5.15B | 538.30M | 11.68% |
| Dec 31, 2005 | 4.61B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 45.13B |
| Medtronic | 35.48B |
| GE HealthCare Technologies | 20.98B |
| Koninklijke Philips | 20.94B |
| Boston Scientific | 20.61B |
| Zimmer Biomet Holdings | 8.41B |
| Edwards Lifesciences | 6.30B |
| Smith & Nephew | 6.16B |
SYK News
- 20 hours ago - Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference - GlobeNewsWire
- 1 day ago - Stryker misses quarterly estimates on muted demand for medical devices - Reuters
- 1 day ago - Stryker First-Quarter Sales, Profit Rise as it Dealt with Cyberattack - WSJ
- 1 day ago - Stryker Earnings Call Transcript: Q1 2026 - Transcripts
- 1 day ago - Stryker reports first quarter 2026 operating results - GlobeNewsWire
- 1 day ago - Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment - GlobeNewsWire
- 7 days ago - Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK) - GlobeNewsWire
- 9 days ago - Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (SYK) - Newsfile Corp